South Carolina H5486 mandates an annual review of treatments for chronic and rare kidney diseases for Medicaid enrollees.
South Carolina H5486 requires the Department of Health and Human Services to annually review medications and treatments for chronic and rare kidney diseases for Medicaid enrollees. The review aims to assess the adequacy of available treatments and recommend potential new treatments. The department must solicit public input, especially from those knowledgeable about kidney diseases, and publish an annual report on its findings and recommendations. The act takes effect upon approval by the Governor.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.